The historical rank and industry rank for Regent Pacific Group's FCF Margin % or its related term are showing as below:
HKSE:00575'
s FCF Margin % Range Over the Past 10 Years
Min: -6086.45 Med: -504.52 Max: 433.11
Current: -1186.87
During the past 13 years, the highest FCF Margin % of Regent Pacific Group was 433.11%. The lowest was -6086.45%. And the median was -504.52%.
HKSE:00575's FCF Margin % is ranked worse than 96.57% of 963
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs HKSE:00575: -1186.87
Regent Pacific Group FCF Margin % Related Terms
Regent Pacific Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for Regent Pacific Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regent Pacific Group FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Regent Pacific Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regent Pacific Group (HKSE:00575) has a FCF Margin % of -1,697.55% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Regent Pacific Group and its competitors. According to the industry distribution chart, Regent Pacific Group ranks #930 out of 963 companies in the Drug Manufacturers industry, placing it in the top 96.6%.
Is Regent Pacific Group's FCF Margin % too high?
Regent Pacific Group's current FCF Margin % is -1,697.55%. Based on the distribution chart, Regent Pacific Group ranks #930 out of 963 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regent Pacific Group has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #930 out of 963 companies for FCF Margin %. This places Regent Pacific Group in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Regent Pacific Group and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regent Pacific Group's current FCF Margin % is -1,697.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Based on GuruFocus' analysis, Regent Pacific Group (HKSE:00575) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.56, compared to a current price of HK$0.92 — trading 64.3% above its estimated fair value. The current FCF Margin % is -1,697.55%. Regent Pacific Group's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Regent Pacific Group (HKSE:00575), the current FCF Margin % is -1,697.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regent Pacific Group (HKSE:00575) Overvalued in 2026?
Based on GuruFocus' analysis, Regent Pacific Group stock appears to be overvalued.
The current stock price of HK$0.92 is trading 64.3% above its estimated GF Value™ of HK$0.56.
GuruFocus considers Regent Pacific Group to be Significantly Overvalued.
Key valuation signals for HKSE:00575:
FCF Margin %: -1,697.55%
GF Value™: HK$0.56 vs. price of HK$0.92 (64.3% above fair value)
No single metric tells the full story. See the HKSE:00575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
12GF Score
Get the complete analysis for HKSE:00575
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00575 has been successfully added to your 
